mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for TATDN3
Gene summary
Basic gene Info.Gene symbolTATDN3
Gene nameTatD DNase domain containing 3
Synonyms-
CytomapUCSC genome browser: 1q32.3
Type of geneprotein-coding
RefGenesNM_001042552.2,
NM_001042553.2,NM_001146169.1,NM_001146170.1,NM_001146171.1,
Descriptionputative deoxyribonuclease TATDN3
Modification date20141207
dbXrefs HGNC : HGNC
Ensembl : ENSG00000203705
Vega : OTTHUMG00000036805
ProteinUniProt: Q17R31
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TATDN3
BioGPS: 128387
PathwayNCI Pathway Interaction Database: TATDN3
KEGG: TATDN3
REACTOME: TATDN3
Pathway Commons: TATDN3
ContextiHOP: TATDN3
ligand binding site mutation search in PubMed: TATDN3
UCL Cancer Institute: TATDN3
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for TATDN3

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H147V146AHNSC1
H170F172LSTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for TATDN3
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H170F172L-1.3221978
H147V146A-1.2855924
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for TATDN3 from PDB

Top
Differential gene expression and gene-gene network for TATDN3
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of TATDN3 and the right PPI network was created from samples without mutations in the LBS of TATDN3. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for TATDN3
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for TATDN3
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of TATDN3 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)2y1hAH147 H170
ZNZINC(2+)2y1hBH147 H170
ZNZINC(2+)2y1hAH170


Top
Conservation information for LBS of TATDN3
Multiple alignments for Q17R31 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas